Recent findings indicated that SARS-CoV-2 related neurological manifestations involve cytokine release syndrome along with endothelial activation, blood brain barrier dysfunction, and immune-mediated mechanisms. Very few studies have fully investigated the CSF correlates of SARS-CoV-2 encephalitis.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses / Pilotto, A., Masciocchi, S., Volonghi, I., De Giuli, V., Caprioli, F., Mariotto, S., Ferrari, S., Bozzetti, S., Imarisio, A., Risi, B., Premi, E., Benussi, A., Focà, E., Castelli, F., Zanusso, G., Monaco, S., Stefanelli, P., Gasparotti, R., Zekeridou, A., Mckeon, A., et al.. - In: CLINICAL INFECTIOUS DISEASES. - ISSN 1058-4838. - ELETTRONICO. - 73:9(2021), pp. e3019-e 3026. [10.1093/cid/ciaa1933]
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses
Benussi, Alberto;
2021-01-01
Abstract
Recent findings indicated that SARS-CoV-2 related neurological manifestations involve cytokine release syndrome along with endothelial activation, blood brain barrier dysfunction, and immune-mediated mechanisms. Very few studies have fully investigated the CSF correlates of SARS-CoV-2 encephalitis.| File | Dimensione | Formato | |
|---|---|---|---|
|
33395482.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
3.6 MB
Formato
Adobe PDF
|
3.6 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
